Cargando…

The Vitamin D Receptor–BIM Axis Overcomes Cisplatin Resistance in Head and Neck Cancer

SIMPLE SUMMARY: Treatment success of head and neck squamous cell carcinoma cancers (HNSCCs) is often hindered by cisplatin resistance. Vitamin D and its receptor (VDR) have been suggested to influence tumor pathobiology and therapy response. We found that VitD/analogs in combination with platinum-ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khamis, Aya, Gül, Désirée, Wandrey, Madita, Lu, Qiang, Knauer, Shirley K., Reinhardt, Christoph, Strieth, Sebastian, Hagemann, Jan, Stauber, Roland H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600548/ https://www.ncbi.nlm.nih.gov/pubmed/36291915 http://dx.doi.org/10.3390/cancers14205131

Ejemplares similares

Exploiting Vitamin D Receptor and Its Ligands to Target Squamous Cell Carcinomas of the Head and Neck
por: Koll, Laura, et al.
Publicado: (2023)

Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer
por: Gül, Désirée, et al.
Publicado: (2022)

Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities
por: Wandrey, Madita, et al.
Publicado: (2023)

Profiling Cisplatin Resistance in Head and Neck Cancer: A Critical Role of the VRAC Ion Channel for Chemoresistance
por: Siemer, Svenja, et al.
Publicado: (2021)

The Magic Triangle in Oral Potentially Malignant Disorders: Vitamin D, Vitamin D Receptor, and Malignancy
por: Khamis, Aya, et al.
Publicado: (2023)

IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
por: Gribko, Alena, et al.
Publicado: (2021)

The Apoptosis Inhibitor Protein Survivin Is a Critical Cytoprotective Resistor against Silica-Based Nanotoxicity
por: Breder-Bonk, Christina, et al.
Publicado: (2023)

Expressional analysis of disease-relevant signalling-pathways in primary tumours and metastasis of head and neck cancers
por: Goesswein, Dorothee, et al.
Publicado: (2018)

Characterization of a novel microfluidic platform for the isolation of rare single cells to enable CTC analysis from head and neck squamous cell carcinoma patients
por: Stiefel, Janis, et al.
Publicado: (2022)

A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer
por: Stauber, Roland H., et al.
Publicado: (2011)

TNF-α-Inhibition Improves the Biocompatibility of Porous Polyethylene Implants In Vivo
por: Hussain, Timon, et al.
Publicado: (2021)

The Taspase1/Myosin1f-axis regulates filopodia dynamics
por: Hensel, Astrid, et al.
Publicado: (2022)

Nano Meets Micro-Translational Nanotechnology in Medicine: Nano-Based Applications for Early Tumor Detection and Therapy
por: Siemer, Svenja, et al.
Publicado: (2020)

Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives
por: Gribko, Alena, et al.
Publicado: (2019)

BIM for Construction Health and Safety
por: Mordue, Stefan, et al.
Publicado: (2019)

Prognostic and Therapeutic Potential of Nuclear Receptors in Head and Neck Squamous Cell Carcinomas
por: Knauer, Shirley K.
Publicado: (2009)

Implementation of Space Charge Forces in BimBim
por: Gottlob, Emmanuel
Publicado: (2017)

Translocation Biosensors – Cellular System Integrators to Dissect CRM1-Dependent Nuclear Export by Chemicogenomics
por: Fetz, Verena, et al.
Publicado: (2009)

Taspase1 Facilitates Topoisomerase IIβ-Mediated DNA Double-Strand Breaks Driving Estrogen-Induced Transcription
por: Oelschläger, Lisa, et al.
Publicado: (2023)

Overexpression of the Catalytically Impaired Taspase1(T234V) or Taspase1(D233A) Variants Does Not Have a Dominant Negative Effect in T(4;11) Leukemia Cells
por: Bier, Carolin, et al.
Publicado: (2012)

BIM Demystified
por: Race, Steve
Publicado: (2019)

Bim Demystified
por: Race, Steve
Publicado: (2012)

BIM Design
por: Garber, Richard
Publicado: (2014)

The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma
por: Tu, Yong-sheng, et al.
Publicado: (2017)

The BIM-manager: a practical guide for BIM project management
por: Baldwin, Mark, et al.
Publicado: (2019)

The NOXA–MCL1–BIM axis defines lifespan on extended mitotic arrest
por: Haschka, Manuel D., et al.
Publicado: (2015)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
por: Wirth, Matthias, et al.
Publicado: (2014)

Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides
por: Liu, Jun, et al.
Publicado: (2017)

BIM in Small Practices
por: Klaschka, Robert
Publicado: (2019)

The BIM management handbook
por: Shepherd, David
Publicado: (2016)

BIM's up first
por: Murphy, Daniel J., et al.
Publicado: (2014)

Boosting nanotoxicity to combat multidrug-resistant bacteria in pathophysiological environments
por: Westmeier, Dana, et al.
Publicado: (2020)

Impact of Peptide Sequences on Their Structure and Function: Mimicking of Virus‐Like Nanoparticles for Nucleic Acid Delivery
por: Jana, Poulami, et al.
Publicado: (2022)

Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia
por: Soh, Sheila Xinxuan, et al.
Publicado: (2014)

Preferential control of induced regulatory T cell homeostasis via a Bim/Bcl-2 axis
por: Wang, X, et al.
Publicado: (2012)

MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma
por: Sun, Yangbai, et al.
Publicado: (2016)

A Combined Systemic Strategy for Overcoming Cisplatin Resistance in Head and Neck Cancer: From Target Identification to Drug Discovery
por: Chen, Yin-Ju, et al.
Publicado: (2020)

Disease-relevant signalling-pathways in head and neck cancer: Taspase1’s proteolytic activity fine-tunes TFIIA function
por: Gribko, Alena, et al.
Publicado: (2017)

Bim plays apoptosis offense
por: Powell, Kendall
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ubbd5i1cu70vrmdvqvhj55b1ni